What the FDA labels say about taking them together
Corticotropin and hetastarch
Hetastarch's FDA label of May 20, 2026 names corticotropin in its warnings and precautions section; the corticotropin labels PlainMeds reads (2) do not name hetastarch.
Check it at the source: the corticotropin FDA label on DailyMed (effective July 15, 2026, Mallinckrodt ARD LLC); the hetastarch FDA label on DailyMed (effective May 20, 2026).
What does the corticotropin label say about hetastarch?
Corticotropin's label (effective July 15, 2026) and its 1 other brand-application label do not name hetastarch in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Acthar), Mallinckrodt ARD LLC, effective July 15, 2026 (SPL set 7b48ddec-e815-45f4-9ca0-5c0daaf56f30), via openFDA; the full label on DailyMed
What does the hetastarch label say about corticotropin?
Hetastarch label, warnings and precautionsCaution must be exercised in the administration of parenteral fluids, especially those containing sodium ions, to patients receiving corticosteroids or corticotropin.
Source: FDA drug label (Hextend), Hospira, Inc., effective May 20, 2026 (SPL set fc79700c-6c3b-4998-8307-4dc8c81c5041), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Corticotropin | Hetastarch | |
|---|---|---|
| Labeled for | Multiple sclerosis, Psoriasis, Eczema (atopic dermatitis) | n/a |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once